ICD-10 Coding for Cologuard® Stool DNA Testing(C18.9, C18.9B, C18.9M)

Learn about ICD-10 coding for Cologuard® stool DNA testing, including primary and secondary codes, documentation requirements, and billing considerations.

Also known as:
Stool DNA TestFIT-DNA Test
Related ICD-10 Code Ranges

Complete code families applicable to Cologuard® Stool DNA Testing

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescription
Z12.11Encounter for screening for malignant neoplasm of colon
R19.5Other fecal abnormalities
C18.9Malignant neoplasm of colon, unspecified

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information

Essential facts and insights aboutCologuard® Stool DNA Testing

Differential Codes

Alternative codes to consider when ruling out similar conditions

Encounter for screening for malignant neoplasm of rectumZ12.12

Use when screening is specifically for rectal cancer.

MelenaK92.1

Use when patient presents with symptoms like melena.

Malignant neoplasm of rectumC20

Use when cancer is localized to the rectum.

Documentation & Coding Risks

Avoid these common issues when documenting Cologuard® Stool DNA Testing.

Vague documentation of stool test results

Impact

Clinical: May lead to inappropriate follow-up procedures., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials or audits.

Mitigation

Specify test type and result in documentation, Use standardized phrases like 'positive Cologuard® test'

Using Z12.11 for symptomatic patients

Impact

Reimbursement: May result in claim denials., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data on screening vs. diagnostic procedures.

Mitigation

Use symptom-specific codes like K92.1 for melena.

Omitting KX modifier for Medicare

Impact

Reimbursement: Potential denial of Medicare claims., Compliance: Non-compliance with CMS guidelines., Data Quality: Inaccurate reporting of screening procedures.

Mitigation

Append KX to G0121/G0105 for compliance.

Screening vs. Diagnostic Coding

Impact

Incorrectly coding diagnostic procedures as screenings.

Mitigation

Ensure documentation clearly states screening intent and patient symptom status.

Frequently Asked Questions